摘要 |
<p>Compounds of the formula (I), and pharmaceutically acceptable salts thereof, are found to be antagonists of SNS sodium channels. They are therefore useful as analgesic and neuroprotective agents, formula (I): R<SUP>1</SUP> represents: (a) -L-A or -L' -A' wherein L represents a bond or a C<SUB>1-</SUB>C<SUB>6 </SUB>alkyl, C<SUB>2</SUB>-C<SUB>6</SUB> alkenyl or C<SUB>2</SUB>-C<SUB>6</SUB> alkynyl moiety, A represents a phenyl, 5- to 10-membered heteroaryl, C<SUB>3</SUB>-C<SUB>6 </SUB>carbocyclyl or 5- to 10-membered heterocyclyl group, L' represents a C<SUB>1</SUB>-C<SUB>6</SUB> alkyl, C<SUB>2</SUB>-C<SUB>6</SUB> alkenyl or C<SUB>2</SUB>-C<SUB>6</SUB> alkynyl moiety, and A' represents -Het-A or -X-A wherein Het represents -O-, -S- or -NR'-, and X represents -CO-, -SO-, -SO<SUB>2</SUB>-, -CO-O-, -CO-S-, -CONR'-, -O-CO-, -S-CO- or -NR'-CO-, wherein R' represents hydrogen or C<SUB>1</SUB>-C<SUB>6</SUB> alkyl; (b) -L-CR(A)(A') or -L-CR(A)(L-A) wherein R is hydrogen or C<SUB>1</SUB>1-C<SUB>4</SUB> alkyl, A' is as defined above, each L is the same or different and is as defined above and each A' is the same or different and is as defined above; (c) -L-A-A' or -L-A-L-A wherein A' and L are as defined above and each A is the same or different and is as defined above; or (d) -A-Z-A wherein Z is -Het-L'-, -X-L'-, -L'-Het- or -L'-X-, wherein Het, L' and X are as defined above and each A is the same or different and is as defined above; J represents -NR<SUP>5</SUP>-, -O- or a direct bond; R<SUP>5</SUP> represents hydrogen, C<SUB>1</SUB>-C<SUB>6</SUB> alkyl, C<SUB>2</SUB>-C<SUB>6</SUB> alkenyl or C<SUB>2</SUB>-C<SUB>6</SUB> alkynyl; R<SUP>4</SUP> is represents hydrogen, C<SUB>1</SUB>-C<SUB>6</SUB> alkyl, C<SUB>2</SUB>-C<SUB>6</SUB> alkenyl or C<SUB>2</SUB>-C<SUB>6</SUB> alkynyl; and either R<SUP>2</SUP> represents -L-A, -L-A', -L-A-A', -L-A-L-A, -L-CR(A)(L-A), -L- CR(A)(A') or -L-CR(A)(L") wherein L" is -Het-L', -X-L', -CONH<SUB>2</SUB> or -CO<SUB>2</SUB>H, and wherein A', Het, X and R are as defined above, each L is the same or different and is as defined above, each A is the same or different and is as defined above and R<SUP>3</SUP> represents hydrogen, C<SUB>1</SUB>-C<SUB>6</SUB> alkyl C<SUB>2</SUB>-C<SUB>6</SUB> alkynyl or (CO)-L', wherein L is as defined above or R<SUP>2</SUP> and R<SUP>3 </SUP>form, together with the nitrogen to which they are attached, a 5-to 10-membered heteroaryl or 5-to 10-membered heterocyclyl ring.</p> |
申请人 |
VERNALIS (R & D) LIMITED;HAMLYN, RICHARD;CALLIS, DAVID;EARNSHAW, CHRISTOPHER, GEOFFREY;FINCH, HARRY;HUCKSTEP, MIKE;LYNCH, ROSEMARY;MELLOR, SARAH |
发明人 |
HAMLYN, RICHARD;CALLIS, DAVID;EARNSHAW, CHRISTOPHER, GEOFFREY;FINCH, HARRY;HUCKSTEP, MIKE;LYNCH, ROSEMARY;MELLOR, SARAH |